News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
216,202 Results
Type
Article (16275)
Company Profile (55)
Press Release (199865)
Multimedia
Podcasts (31)
Webinars (3)
Section
Business (55854)
Career Advice (722)
Deals (8747)
Drug Delivery (56)
Drug Development (31707)
Employer Resources (62)
FDA (5434)
Job Trends (5316)
News (100539)
Policy (8007)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
Academia (1172)
Accelerated approval (16)
Adcomms (8)
Allergies (45)
Alliances (16123)
ALS (78)
Alzheimer's disease (827)
Antibody-drug conjugate (ADC) (203)
Approvals (5584)
Artificial intelligence (248)
Autoimmune disease (62)
Automation (16)
Bankruptcy (59)
Best Places to Work (4616)
BIOSECURE Act (3)
Biosimilars (38)
Biotechnology (35)
Bladder cancer (54)
Brain cancer (32)
Breast cancer (274)
Cancer (2474)
Cardiovascular disease (161)
Career advice (654)
Career pathing (19)
CAR-T (71)
CDC (5)
Celiac Disease (2)
Cell therapy (229)
Cervical cancer (11)
Clinical research (27061)
Collaboration (746)
Company closure (3)
Compensation (233)
Complete response letters (24)
COVID-19 (950)
CRISPR (43)
C-suite (375)
Cystic fibrosis (88)
Data (2821)
Denatured (12)
Depression (46)
Diabetes (189)
Diagnostics (2181)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (17)
Drug discovery (133)
Drug pricing (75)
Drug shortages (3)
Duchenne muscular dystrophy (87)
Earnings (19369)
Editorial (22)
Employer branding (7)
Employer resources (60)
Events (31747)
Executive appointments (393)
FDA (6665)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (12)
Funding (669)
Gene editing (84)
Generative AI (27)
Gene therapy (228)
GLP-1 (432)
Government (1382)
Grass and pollen (2)
Guidances (149)
Healthcare (6256)
HIV (25)
Huntington's disease (28)
IgA nephropathy (39)
Immunology and inflammation (98)
Immuno-oncology (24)
Indications (52)
Infectious disease (1058)
Inflammatory bowel disease (78)
Inflation Reduction Act (11)
Influenza (39)
Intellectual property (100)
Interviews (136)
IPO (4278)
IRA (26)
Job creations (835)
Job search strategy (532)
JPM (31)
Kidney cancer (7)
Labor market (26)
Layoffs (166)
Leadership (19)
Legal (1132)
Liver cancer (47)
Longevity (8)
Lung cancer (637)
Lymphoma (183)
Machine learning (23)
Management (23)
Manufacturing (301)
MASH (70)
Medical device (4510)
Medtech (4528)
Mergers & acquisitions (4766)
Metabolic disorders (516)
Multiple sclerosis (56)
NASH (7)
Neurodegenerative disease (159)
Neuropsychiatric disorders (31)
Neuroscience (1408)
Neurotech (1)
NextGen: Class of 2026 (2336)
Non-profit (2816)
Now hiring (9)
Obesity (237)
Opinion (175)
Ovarian cancer (72)
Pain (67)
Pancreatic cancer (89)
Parkinson's disease (167)
Partnered (14)
Patents (160)
Patient recruitment (183)
Peanut (19)
People (18664)
Pharmaceutical (11)
Pharmacy benefit managers (7)
Phase 1 (9293)
Phase 2 (12422)
Phase 3 (8324)
Pipeline (2259)
Policy (99)
Postmarket research (644)
Preclinical (3771)
Press Release (20)
Prostate cancer (101)
Psychedelics (13)
Radiopharmaceuticals (124)
Rare diseases (396)
Real estate (1451)
Recruiting (25)
Regulatory (7158)
Reports (18)
Research institute (1153)
Resumes & cover letters (85)
Rett syndrome (7)
RNA editing (2)
RSV (34)
Schizophrenia (63)
Series A (113)
Series B (79)
Service/supplier (2)
Sickle cell disease (47)
Special edition (9)
Spinal muscular atrophy (169)
Sponsored (25)
Startups (1352)
Stomach cancer (9)
Supply chain (29)
Tariffs (33)
The Weekly (19)
Vaccines (323)
Venture capital (52)
Weight loss (140)
Women's health (27)
Worklife (10)
Date
Last 7 days (214)
Last 30 days (853)
Last 365 days (11142)
2026 (1144)
2025 (11133)
2024 (12732)
2023 (14627)
2022 (19804)
2021 (20034)
2020 (18416)
2019 (17702)
2018 (13251)
2017 (10598)
2016 (9961)
2015 (11265)
2014 (7569)
2013 (5920)
2012 (6212)
2011 (6663)
2010 (5428)
Location
Africa (287)
Alabama (57)
Alaska (3)
Arizona (65)
Arkansas (7)
Asia (13567)
Australia (2225)
California (4137)
Canada (859)
China (517)
Colorado (106)
Connecticut (184)
Delaware (157)
Europe (30122)
Florida (524)
Georgia (130)
Idaho (13)
Illinois (276)
India (23)
Indiana (143)
Iowa (11)
Japan (199)
Kansas (39)
Kentucky (14)
Louisiana (8)
Maine (13)
Maryland (469)
Massachusetts (2991)
Michigan (103)
Minnesota (129)
Mississippi (3)
Missouri (52)
Montana (14)
Nebraska (13)
Nevada (36)
New Hampshire (22)
New Jersey (1066)
New Mexico (17)
New York (1154)
North Carolina (524)
North Dakota (6)
Northern California (2076)
Ohio (88)
Oklahoma (9)
Oregon (24)
Pennsylvania (593)
Puerto Rico (5)
Rhode Island (17)
South America (340)
South Carolina (14)
South Dakota (1)
Southern California (1654)
Tennessee (42)
Texas (580)
United States (13863)
Utah (102)
Virginia (70)
Washington D.C. (21)
Washington State (297)
West Virginia (2)
Wisconsin (43)
216,202 Results for "sma foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
The Novo Nordisk Foundation’s funds will go toward supporting early-stage companies working in “human health, planetary health and societal resilience.”
January 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
November 25, 2025
·
8 min read
FDA
September’s FDA Action Bolsters Keytruda, Ultra-Rare Disease but Deals Two SMA Defeats
The FDA in September issued two rejections for spinal muscular atrophy therapies—both linked to manufacturing problems—and granted approvals in Barth syndrome and for a subcutaneous version of Merck’s Keytruda that could be key to the blockbuster’s future earnings.
September 29, 2025
·
10 min read
·
Tristan Manalac
Press Releases
New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA
June 30, 2025
·
9 min read
Press Releases
Ionis announces Biogen to advance salanersen into SMA registrational studies based on positive interim Phase 1 results
June 25, 2025
·
8 min read
Press Releases
FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish Facility
September 23, 2025
·
8 min read
Press Releases
Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)
June 4, 2025
·
8 min read
Press Releases
Pivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted Treatment
August 15, 2025
·
10 min read
Press Releases
Bacterial Mechanism That Could Help Prevent and Treat Lyme Arthritis Identified by New Bay Area Lyme Foundation–Supported Study
January 21, 2026
·
4 min read
C-suite
UPDATE: Novo Foundation Completes Board Takeover After Shareholder Pushback
“As the future chair I will attend to the interests of not only the Novo Nordisk Foundation but all shareholders of the company,” incoming chair and former Novo Nordisk CEO Lars Rebien Sørensen said at the meeting held Friday.
November 14, 2025
·
5 min read
·
Annalee Armstrong
1 of 21,621
Next
